Pillar Clinical Research -Chicago

Clinical research site in Chicago, Illinois · Pillar Clinical Research, Chicago, Illinois, 3400 N Pulaski Rd, Chicago, IL 60641 · (224) 534-7332 · Website

Part of Pillar Clinical Research

As of July 2026, 8 paid clinical trials are recruiting at Pillar Clinical Research -Chicago in Chicago, Illinois. Active studies at this site cover conditions such as Bipolar I Disorder, Bipolar Disorder Type I With Mania and Bipolar II Disorder. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Pillar Clinical Research -Chicago (8)

Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.

for Bipolar I Disorder

26 locations incl. Bentonville

Sponsor: LB Pharmaceuticals Inc.

Sex: All·Age: 18 - 65

Code: NCT07494305·Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

for Bipolar Disorder Type I With Mania

46 locations incl. Glendale

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18 - 65

Code: NCT06929273·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

for Bipolar I Disorder

33 locations incl. Huntsville

Sponsor: AbbVie

Sex: All·Age: 18 - 65

Code: NCT06696755·Phase 2·Recruiting·Listed Nov 2024

Apply to this trial

Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

for Schizophrenia

13 locations incl. Bentonville

Sponsor: LB Pharmaceuticals Inc.

Sex: All·Age: 18 - 65

Code: NCT07363577·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

A Study to Evaluate the Effect of KarXT on Urological Safety

for Schizophrenia

13 locations incl. Little Rock

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18 - 65

Code: NCT07221877·Phase 4·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

for Mania

20 locations incl. Bentonville

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18 - 65

Code: NCT07140913·Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder

for Bipolar 1 Disorder

16 locations incl. Little Rock

Sponsor: Rapport Therapeutics Inc.

Sex: All·Age: 18 - 65

Code: NCT07046494·Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder

for Bipolar-I Disorder With Mania or Mania With Mixed Features

21 locations incl. Bentonville

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18 - 65

Code: NCT06951698·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

More research sites in Chicago

Northwestern University (341 trials)
University of Chicago (182 trials)
Rush University Medical Center (151 trials)
Ann & Robert H. Lurie Children's Hospital of Chicago (113 trials)
University of Chicago Medical Center (98 trials)
Northwestern Memorial Hospital (87 trials)
University of Chicago Comprehensive Cancer Center (87 trials)
University of Illinois (84 trials)
University of Illinois at Chicago (72 trials)
Advocate Illinois Masonic Medical Center (50 trials)

Explore more

Paid clinical trials in Chicago, IL · Illinois clinical trials